It is also reported that the genes with the highest frequencies of mutation in AML‐MRC were ASXL1, TP53, RUNX1, and DNMT3A, of 21%, 28%, 12%, and 9%,14, 15 which were predicted to a poor prognosis. This evidence concerns the gene TP53 and acute myeloid leukemia.